Literature DB >> 3196491

Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.

F Chiodi1, J Albert, E Olausson, G Norkrans, L Hagberg, A Sönnerborg, B Asjö, E M Fenyö.   

Abstract

Isolation of the human immunodeficiency virus (HIV) has been attempted from the cerebrospinal fluid (CSF) of 63 subjects at different stages of HIV infection, including asymptomatic carriers and patients with or without neurologic or psychiatric complications. In addition blood was collected from 40 of these subjects for virus isolation. HIV could be isolated from the CSF at all clinical stages with an overall frequency of 40%. In contrast, the frequency of HIV isolation from the blood was lower (32%) at the early stages of infection than in patients with severe disease (77%). HIV isolation from the CSF was more frequently positive in patients with neurologic or psychiatric complications than in patients showing no such disturbances (48 and 32%, respectively).

Entities:  

Mesh:

Year:  1988        PMID: 3196491     DOI: 10.1089/aid.1988.4.351

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection.

Authors:  Xue Wang; Paul Foryt; Renee Ochs; Jae-Hoon Chung; Ying Wu; Todd Parrish; Ann B Ragin
Journal:  Brain Connect       Date:  2011

Review 3.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

4.  Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.

Authors:  F Chiodi; B Keys; J Albert; L Hagberg; J Lundeberg; M Uhlén; E M Fenyö; G Norkrans
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 5.  Insights into the role of immune activation in HIV neuropathogenesis.

Authors:  Suzanne Gartner; Yiling Liu
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

Review 6.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.

Authors:  Hongwei Wang; Jinglin Sun; Harris Goldstein
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 8.  SIV Latency in Macrophages in the CNS.

Authors:  Lucio Gama; Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Kelly A Metcalf Pate; Brandon T Bullock; M Christine Zink; Joseph L Mankowski; Janice E Clements
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

9.  Brain macrophages harbor latent, infectious simian immunodeficiency virus.

Authors:  Celina Abreu; Erin N Shirk; Suzanne E Queen; Sarah E Beck; Lisa M Mangus; Kelly A M Pate; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  AIDS       Date:  2019-12-01       Impact factor: 4.177

Review 10.  A critical analysis of the HIV-T4-cell-AIDS hypothesis.

Authors:  E Papadopulos-Eleopulos; V F Turner; J M Papadimitriou; D Causer; B Hedland-Thomas; B A Page
Journal:  Genetica       Date:  1995       Impact factor: 1.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.